Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial (Q83441006)
Jump to navigation
Jump to search
scientific article published on 13 February 2012
Language | Label | Description | Also known as |
---|---|---|---|
English | Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial |
scientific article published on 13 February 2012 |
Statements
Minimal residual disease quantification is an independent predictor of progression-free and overall survival in chronic lymphocytic leukemia: a multivariate analysis from the randomized GCLLSG CLL8 trial (English)
Stephan Stilgenbauer
Sebastian Böttcher
Matthias Ritgen
Kirsten Fischer
Raymonde M Busch
Günter Fingerle-Rowson
Anna Maria Fink
Andreas Bühler
Thorsten Zenz
Michael Karl Wenger
Myriam Mendila
Clemens-Martin Wendtner
Barbara F Eichhorst
Hartmut Döhner
Michael J Hallek
13 February 2012